We are live on
!
Find out more
CAPTRUST Financial Advisors Portfolio holdings
AUM
$57.3B
1-Year Est. Return
18.32%
This Fund
S&P 500
This Quarter
Est. Return
+2.32%
1 Year Est. Return
+18.32%
3 Year Est. Return
+60%
5 Year Est. Return
+73.18%
10 Year Est. Return
+239.88%
AUM
$52.6B
AUM Growth
+$3.54B
(+7.2%)
Cap. Flow
+$2.86B
Cap. Flow
% of AUM
5.43%
Top 10 Holdings %
Top 10 Hldgs %
26.97%
Holding
2,839
New
218
Increased
1,508
Reduced
890
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$202M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$181M |
| 3 |
BPRE
Bluerock Private Real Estate Fund
BPRE
|
+$122M |
| 4 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$117M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mega Cap Growth ETF
MGK
|
+$219M |
| 2 |
Vanguard Growth ETF
VUG
|
+$76M |
| 3 |
Deere & Co
DE
|
+$68.8M |
| 4 |
Dimensional US High Profitability ETF
DUHP
|
+$62.7M |
| 5 |
Iron Mountain
IRM
|
+$48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.66% |
| 2 | Financials | 7.63% |
| 3 | Healthcare | 4.78% |
| 4 | Industrials | 3.98% |
| 5 | Communication Services | 3.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ODV
2626
DELISTED
Osisko Development Corp
ODV
| $85.5K | ﹤0.01% |
24,500
+7,500
| +44% | +$25.8K |
|
2627
Corvus Pharmaceuticals
CRVS
$1.12B
| $85.1K | ﹤0.01% |
+11,051
| New | +$87.1K |
|
2628
Nuveen Credit Strategies Income Fund
JQC
$704M
| $83.9K | ﹤0.01% |
16,706
-25,216
| -60% | -$128K |
|
2629
Taysha Gene Therapies
TSHA
$1.66B
| $83.1K | ﹤0.01% |
+15,113
| New | +$73.4K |
|
|
IGR
2630
CBRE Global Real Estate Income Fund
IGR
$713M
| $83K | ﹤0.01% |
18,957
| – | – |
|
2631
Redwire
RDW
$2.18B
| $82.9K | ﹤0.01% |
+10,914
| New | +$80.1K |
|
2632
Armata Pharmaceuticals
ARMP
$167M
| $82.5K | ﹤0.01% |
13,140
| – | – |
|
2633
Invesco Senior Income Trust
VVR
$457M
| $81K | ﹤0.01% |
24,780
| – | – |
|
2634
Ocugen
OCGN
$433M
| $81K | ﹤0.01% |
60,000
-2
| -0% | -$3 |
|
2635
Pacific Biosciences
PACB
$429M
| $80.3K | ﹤0.01% |
+42,959
| New | +$82.5K |
|
2636
Acco Brands
ACCO
$374M
| $80.2K | ﹤0.01% |
21,508
-3,259
| -13% | -$12.1K |
|
|
NXDR
2637
Nextdoor Holdings
NXDR
$858M
| $80K | ﹤0.01% |
38,116
-3,075
| -7% | -$6.03K |
|
2638
SITE Centers
SITC
$232M
| $77.4K | ﹤0.01% |
+12,054
| New | +$91.1K |
|
2639
Methode Electronics
MEI
$555M
| $77.2K | ﹤0.01% |
11,628
-915
| -7% | -$6.49K |
|
2640
Senseonics Holdings Inc
SENS
$263M
| $77.1K | ﹤0.01% |
+13,975
| New | +$97.2K |
|
2641
Cerus
CERS
$603M
| $76.3K | ﹤0.01% |
37,051
+4,916
| +15% | +$8.52K |
|
2642
Lifestance Health
LFST
$4.18B
| $74.4K | ﹤0.01% |
10,566
-1,125
| -10% | -$6.79K |
|
|
UNIT
2643
Uniti Group
UNIT
$2.65B
| $73.8K | ﹤0.01% |
+10,531
| New | +$66.7K |
|
2644
Allogene Therapeutics
ALLO
$642M
| $72.7K | ﹤0.01% |
53,101
+37,386
| +238% | +$49.3K |
|
2645
Cytek Biosciences
CTKB
$577M
| $70.9K | ﹤0.01% |
14,047
-1,231
| -8% | -$5.72K |
|
2646
SIGA Technologies
SIGA
$229M
| $70.8K | ﹤0.01% |
11,590
+679
| +6% | +$4.83K |
|
|
DCH
2647
Dauch Corp
DCH
$1.33B
| $70.4K | ﹤0.01% |
10,977
-52
| -0.5% | -$323 |
|
2648
Epsilon Energy
EPSN
$173M
| $70.3K | ﹤0.01% |
15,146
+2,607
| +21% | +$12.6K |
|
2649
Recursion Pharmaceuticals
RXRX
$1.65B
| $70K | ﹤0.01% |
+17,108
| New | +$84.7K |
|
2650
B&G Foods
BGS
$287M
| $70K | ﹤0.01% |
16,272
-1,799
| -10% | -$8.04K |
|
Similar funds
NAMI
CAPTRUST Financial Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, CAPTRUST Financial Advisors held 2,839 positions worth $52.6B, up 7.2% from $49B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
CAPTRUST Financial Advisors deployed $2.86B of net new capital in Q4 2025, opening 218 new positions and adding to 1,508 existing holdings. Its largest new stake was Bluerock Private Real Estate Fund: 7,879,641 shares worth $118M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Vanguard Mega Cap Growth ETF, an estimated $219M trimmed.
- CAPTRUST Financial Advisors's largest Q4 2025 buy was Bluerock Private Real Estate Fund: 7,879,641 shares worth $118M.
- CAPTRUST Financial Advisors added most to iShares Core MSCI Total International Stock ETF in Q4 2025, an estimated $202M increase.
- CAPTRUST Financial Advisors's biggest Q4 2025 reduction was Vanguard Mega Cap Growth ETF, cutting an estimated $219M.
- CAPTRUST Financial Advisors fully exited Invesco BulletShares 2025 Corporate Bond ETF in Q4 2025, selling an estimated $34.6M.
- CAPTRUST Financial Advisors's ten largest holdings make up 27% of its $52.6B portfolio in Q4 2025.
- CAPTRUST Financial Advisors opened 218 new positions and closed 104 in Q4 2025.
- CAPTRUST Financial Advisors's portfolio value rose 7.2% quarter-over-quarter to $52.6B.
Based on CAPTRUST Financial Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.